Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
| TEVA PHARMACEUTICALS INTERNATIONAL GMBH and TEVA PHARMACEUTICALS USA, INC. |
| ELI LILLY AND COMPANY |
| 24-1149 |
| November 14, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Note to File: The following cases are consolidated: 24-1094 Lead with 24-1149 Cross-Appeal. The parties must file all documents in the lead appeal only. [963355] [24-1094, 24-1149] [KMH] [Entered: 11/14/2023 02:25 PM] |
| Filing 1 Appeal docketed. Received: 11/08/2023. [963351] Entry of Appearance due 11/28/2023. Certificate of Interest is due on 11/28/2023. Docketing Statement due 11/28/2023. Appellant/Petitioner's brief is due 01/16/2024. [KMH] [Entered: 11/14/2023 02:22 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
